Modern Diagnostics and Therapy for Vitreoretinal Diseases

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: 10 October 2025 | Viewed by 1375

Special Issue Editors


E-Mail Website
Guest Editor
1. Retina Associates of Kentucky, 120 N Eagle Creek Dr, Lexington, KY 40509, USA
2. EyeCare Partners, St. Louis, MO, USA
Interests: ophthalmology; retinal disease; retinal pharmacotherapy; artificial intelligence; retinal diagnostic imaging

E-Mail Website
Guest Editor
Department of Ophthalmology, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel
Interests: ophthalmology; retina; retinal imaging; diabetic retinopathy; surgical retina; cell therapy

Special Issue Information

Dear Colleagues,

Therapies for vitreoretinal diseases have grown by leaps and bounds over the last five years. Longer-acting agents for the treatment of exudative disease and a plethora of available and experimental therapies for geographic atrophy now abound. Simultaneously, the diagnostic platforms to help evaluate retinal conditions continue to evolve.

Meanwhile, artificial intelligence (AI) and remote monitoring are becoming more prevalent in ophthalmic diagnostics. Image-recognition-based deep learning is allowing for large-scale data assessments related to ophthalmic testing and imaging. For example, this technology is proving to be useful in studying fluid dynamics in exudative retinal disease and for predictive modeling in non-exudative macular degeneration.

This Special Issue aims to bring together the current state of clinical and laboratory data regarding retinal diagnostics and therapies. Relevant topics should include but are not limited to pharmacotherapy, optical coherence tomography, remote retinal monitoring, artificial intelligence in retinal diagnostics, image recognition platforms, and surgical innovations.

Colleagues are invited to submit original research, meta-analyses, and topical reviews for the Special Issue “Modern Diagnostics and Therapies for Vitreoretinal Disease” to further our knowledge base in this important field.

Sincerely,

Dr. Miguel Antonio Busquets
Prof. Dr. Anat Lowenstein
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • retinal pharmacotherapy
  • artificial intelligence
  • image recognition
  • optical coherence tomography
  • remote retinal monitoring
  • exudative retinal disease
  • geographic atrophy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 295 KiB  
Review
The Neutrophil to Lymphocyte Ratio and Other Full Blood Count Indices in Retinal Diseases: A Systematic Review of the Literature
by Dimitrios Kazantzis, Genovefa Machairoudia, Panagiotis Theodossiadis and Irini Chatziralli
Medicina 2025, 61(1), 125; https://doi.org/10.3390/medicina61010125 - 14 Jan 2025
Viewed by 994
Abstract
Background and Objectives: The neutrophil to lymphocyte ratio (NLR) and other full blood count indices have been used as a marker of inflammation in a variety of diseases. The aim of the current review is to summarize the existing knowledge on the use [...] Read more.
Background and Objectives: The neutrophil to lymphocyte ratio (NLR) and other full blood count indices have been used as a marker of inflammation in a variety of diseases. The aim of the current review is to summarize the existing knowledge on the use of these indices in retinal diseases. Materials and Methods: A systematic review of the literature was conducted to find eligible articles. The PUBMED and Scopus databases were systematically searched for relevant studies examining full blood count indices in retinal diseases. Results: The NLR was elevated in a number of vitreoretinal conditions, such as wet age-related macular degeneration (AMD), diabetic retinopathy and retinal vein occlusion, compared to controls. Full blood count indices could be useful in predicting the response to anti-VEG treatment in patients with wet AMD or diabetic macular edema (DME). Conclusions: The NLR and other indices can be used as diagnostic markers in retinal diseases and as prognostic factors of the response to treatment. The small sample size and short follow-up of the included studies and the variation in the measurement and cutoffs used for the NLR are limitations of its use in retinal conditions. Future studies need to further validate these findings and try to establish a link between these ratios and retinal phenotypes. Full article
(This article belongs to the Special Issue Modern Diagnostics and Therapy for Vitreoretinal Diseases)
Back to TopTop